May. 26 at 9:34 PM
$NEUP
Neuphoria Therapeutics reported quarterly earnings of
$6.55 per share. This is a 331.45 percent increase over losses of $(2.83) per share from the same period last year. The company reported
$15.00 million in sales this quarter.